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deviation. Within each BH, the set-up remained stable within 1.0 mm. 
EPID images showed that σintra was 1.4 mm in both u- and v-directions, 
increasing the σtotal by about 0.5 mm (depending on the value of σinter). 
σinter was 1.2 and 1.7 mm with online CBCT protocol, but recalculated 
to be 2.3 and 2.7 mm in case of set-up on laser marks only. Without 
protocol, Σu would have been 3.3 mm and Σv 2.7 mm; with an online 
CBCT protocol this reduced to 1.2 (u) and 1.4 (v) mm. Because many 
patients changed their BH pattern during or after the first week of 
treatment, both the offline NAL and weekly eNAL protocols were less 
effective, indicating that more intensive imaging protocols have to be 
applied. CTV-PTV margins can be reduced from 10 mm (no protocol) 
to 7 mm with a weekly eNAL protocol, 5 mm with a daily eNAL 
protocol, or 4 mm with an online protocol.  
Conclusions: For accurate radiotherapy breast treatments using a 
voluntary DIBH technique a daily imaging protocol is required. 
Although CBCT provides full information about patient positioning and 
is needed for a 3D treatment beam setup, imaging of the medio-
lateral beam can be a fair alternative for treatments with tangential 
beams only, resulting in a decrease of patient dose. 
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Purpose/Objective: To explore the potential of scanned helium ion 
beams compared to scanned proton beam therapy in a treatment 
planning study. The physical characteristics of helium ions (different 
peak to plateau ratio and sharper beam penumbra) seem to make it a 
promising candidate for radiation oncology. 
Materials and Methods: All treatment plans were created with the 
treatment planning system Hyperion, utilizing a novel pencil beam 
algorithm for both proton and helium ion beams. Employing the same 
conceptual dose calculation algorithm for both ions enables a precise 
comparison without having to account for deviations within 
algorithms. Sample treatment plans were calculated for prostate 
cases and skull base tumours. For both scenarios two laterally opposed 
beams were applied. Treatment plan optimisation was done with the 
same algorithm, constraints and scanning pattern for a given 
treatment site for both particle species.  
Prostate patients received 78 Gy to the PTV, defined as the CTV with 
an isotropic 5mm margin. For the prostate plans two organs at risk 
(rectum and bladder) were delineated. 
The skull base patients were prescribed 54 Gy to the PTV, delineated 
using the CTV plus a 3mm isotropic margin. For the skull base plans 
five organs at risk (eyes, optic nerves and brainstem) were delineated. 
Results were evaluated using dose volume histograms (DVH) and 
target coverage and conformity. 
Results: Two prostate patients have been evaluated so far (PTV 
volumes ~126 ccm). Dmedian for both patients was 78.7 ± 0.4 Gy. D2% for 
prostate patient 1 was 80.1 vs 79.8 Gy with a V95% of 98.6 vs 99.2 % for 
protons and helium ions, respectively. Corresponding values for 
patient 2 were similar (D2% of 80.5 vs 79.8 Gy with a V95% of 98.7 vs 
99.2 % for protons or helium ions). The conformity index for patient 1 
was 0.06 vs 0.04 for protons and helium ions, for patient 2 0.07 vs 
0.04. 
For the skull base patient 1 (average PTV 81.7 ccm) PTV Dmedian was 
54.3 ± 0.1 Gy for both particles. D2% was 56.2 vs 55.6 Gy with a V95% of 
96.1 vs 98.6 % for protons and helium ions, respectively. 
Corresponding values for patient 2, having a smaller PTV (volume of 
30.9 cm), were: D2% 55.8 vs 55.4 Gy with a V95% of 97.6 vs 99.3 % for 
protons or helium ions. The conformity index for skull base patient 1 
was 0.11 vs 0.07, for patient 2 0.09 vs 0.05 for protons and helium 
ions.  
Organ at risk doses for both patients did not exceed the tolerance 
values as specified in the QUANTEC report. 
Conclusions: Systematically steeper PTV DVH curves were obtained 
for helium ions, with a reduced D2% and increasing V95%. The dosimetric 
improvements of treatment plan parameters when using helium ions 
compared to protons motivate a more thorough investigation of 
helium ions. Current work in progress deals with improvements in RBE 
modelling of helium ions during optimisation to fine tune the model.  
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Purpose/Objective: Internal target and organ motion during 
treatment is a challenge in radiotherapy (RT) of the prostate and the 
involved elective targets, with residual motion being present also 
following image-guidance strategies. The aim of this study was to 
investigate organ motion induced dose degradations for the prostate, 
seminal vesicle and the pelvic lymph node targets when treating these 
targets with proton therapy, using different image-guidance and 
delivery strategies. 
Materials and Methods: Four patients were selected from a larger 
series as they displayed large inter-fractional variation in bladder and 
rectum volume. Intensity-modulated proton therapy (IMPT) plans were 
generated using both simultaneous integrated (SIB) and sequential 
boost delivery. For each technique, three isotropic margin expansions 
(in the range of 4-10mm) were evaluated for the clinical target 
volume of prostate (CTV-p), seminal vesicles (CTV-sv) and lymph 
nodes (CTV-ln). Simulation of the dose degradations for all treatment 
plans were based on dose re-calculations for the 8-9 repeat CTs 
available for each patient, after applying rigid registrations to 
reproduce set-up based on either intra-prostatic fiducials or bony 
anatomy. 
Results: The simulated dose received by 99% of the target volume 
(D99) and generalized equivalent dose (gEUD) showed substantial 
inter-patient variations. For 40% of the investigated scenarios, the 
patient average simulated D99 for all targets were within 2GyE from 
the planned. The largest difference between simulated and planned 
dose was seen for the CTV-sv when using SIB delivery, with an average 
relative reduction in D99 of 13% and 15% for the largest margin 
expansion, when positioned using fiducials and bony anatomy 
respectively (Table 1). 
 
  
Conclusions: The most severe dose degradations were found for the 
seminal vesicles, but they were also evident for the lymph node 
target. The degradations could not be completely resolved, neither by 
using the largest margin expansion nor with the choice of set-up. With 
fiducial set-up the prostate target was robust against the inter-
fraction changes. 
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